6797.Two

6797.TWO has a liquidity position that is currently medium, with a current ratio of 3.04, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's free cash flow is negative at -125.6 million TWD, and operating cash flow is also negative at -20.96 million TWD, suggesting cash generation is a challenge. The company's cash and equivalents amount to 193.25 million TWD, but this is offset by long-term debt of 407.84 million TWD, resulting in a negative net cash position.

Profitability metrics for 6797.TWO are weak, with a return on equity of -29.34% and a return on assets of -18.14%, both significantly below the industry median for the Advanced Medical Equipment & Technology sector. The company is currently reporting a net loss of 226.61 million TWD, with operating income also in the red at -232.34 million TWD. These figures indicate that the company is not generating returns that meet the cost of capital and is underperforming relative to its peers.

The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no geographic diversification provided in the available data. This lack of diversification increases the company's exposure to market-specific risks, particularly in its primary operating region. The absence of segment or geographic breakdowns in the financial data limits the ability to assess the company's exposure to different markets or product lines.

Looking ahead, the company's growth trajectory is uncertain, as the available data does not provide forward-looking revenue guidance or outlook for the current or next fiscal year. The company's capital expenditure of -2.45 million TWD suggests minimal investment in new projects or capacity, which may limit future growth potential. The company's negative operating and free cash flows also suggest that it may need to rely on external financing to fund operations or expansion, which could impact its financial flexibility.

The company faces several risk factors, including liquidity risk due to its negative free cash flow and net cash position. The risk assessment indicates a medium liquidity risk, with the company's cash and equivalents not sufficient to cover its long-term debt. The dilution risk is currently low, with no significant dilution expected in the near term, as the number of shares outstanding remains unchanged between basic and diluted shares. However, the company's negative net income and operating cash flow could lead to future dilution if it needs to raise capital to fund operations.

Recent events and filings for 6797.TWO are not detailed in the available data, but the company's financial performance suggests potential challenges in maintaining profitability and generating positive cash flows. The company's negative net income and operating cash flow may indicate operational inefficiencies or market challenges that need to be addressed.